No products in the cart.
10
Jan
Jan
Jan 10 (Reuters) – Swiss drugmaker Idorsia (IDIA.S) said on Monday it has received the U.S. Food and Drug Administration’s approval for its treatment for insomnia in adult patients. The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg based on data from two late-stage […]